Pathophysiology of insulin resistance

2006; Elsevier BV; Volume: 20; Issue: 4 Linguagem: Inglês

10.1016/j.beem.2006.09.007

ISSN

1532-1908

Autores

Giorgio Sesti,

Tópico(s)

Growth Hormone and Insulin-like Growth Factors

Resumo

Insulin resistance is a feature of a number of clinical disorders, including type 2 diabetes/glucose intolerance, obesity, dyslipidaemia and hypertension clustering in the so-called metabolic syndrome. Insulin resistance in skeletal muscle manifests itself primarily as a reduction in insulin-stimulated glycogen synthesis due to reduced glucose transport. Ectopic lipid accumulation plays an important role in inducing insulin resistance. Multiple defects in insulin signalling are responsible for impaired glucose metabolism in target tissues of subjects with features of insulin resistance. Inflammatory molecules and lipid metabolites inhibit insulin signalling by stimulating a number of different serine kinases which are responsible for serine phosphorylation of Insulin Receptor Substrate-1 (IRS-1).

Referência(s)